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ABSTRACT
Leptospirosis is one of the main re-emerging zoonotic 
diseases with a worldwide distribution, mainly in regions 
with hot or tropical climates. It is caused by the spirochetal 
bacteria of the genus Leptospira, which, in their pathogenic 
life forms, causes asymptomatic to severe infections in hu-
mans and animals. Animal-to-human transmission occurs 
most frequently in occupationally exposed groups and in tra-
velers. However, leptospirosis also represents a disease asso-
ciated with poverty and low sanitation environments, in rural 
and urban communities, in close contact with companion 
animals and livestock. A search was performed in PubMed, 
Scopus, Web of Science and Google scholar databases using 
query terms related to Leptospira/leptospirosis, reported 
during 1990-2020. This review focuses on the description of 
biologic and socioenvironmental drivers that influence the 
occurrence of the disease in humans. Leptospirosis is found at 
the human-animal-environment interfaces, and represents a 
challenge for public and animal health, and food production; 
hence, improving the strategies for prevention control and 
surveillance in Latin-American countries is critical, as one of 
the regions most affected by the disease.
Key words: Leptospirosis, human-animal-environment in-
terfaces, drivers of occurrence, Latin-America.
RESUMEN
La leptospirosis es una de las principales enfermeda-
des zoonóticas de distribución mundial, principalmente en 
regiones con climas cálidos o tropicales. Es ocasionada por la 
espiroqueta del género Leptospira, se presenta clínicamente 
de forma asintomática, con cuadros moderados o graves en 
humanos y animales. La transmisión de animal a humanos 
es más frecuente en grupos ocupacionalmente expuestos 
como trabajadores agrícolas y ganaderos, veterinarios, caza-
dores, trabajadores de rastros e incluso viajeros. Asimismo, 
también representa una enfermedad asociada a pobreza y 
ambientes de bajo saneamiento, en comunidades rurales y 
urbanas, en contacto cercano con animales domésticos y ga-
nado. Se realizó una búsqueda en bases de datos de PubMed, 
Scopus, Web of Science y Google scholar, usando palabras 
claves Leptospira/leptospirosis en el periodo 1990-2020. La 
revisión se enfoca en la descripción de determinantes bioló-
gicos y socioambientales que influyen en la ocurrencia de la 
enfermedad en humanos. La leptospirosis se encuentra en la 
interfase de la salud humana y animal, y representa un reto 
para la salud pública, animal, y la producción de alimentos; 
por lo que es crítica la mejora en las estrategias de preven-
ción, control y vigilancia en países de Latinoamérica, una de 
las regiones más afectadas por la enfermedad. 
Palabras clave: Leptospirosis, interfaz humano-animal-
ambiente, determinantes de ocurrencia, Latinoamérica.
INTRODUCTION
The current SARS-CoV-2 pandemic is the latest exam-
ple of the importance of zoonotic diseases, which are those 
transmitted from animals to humans, and are estimated to 
cause around 70 % of human infectious diseases (Jones et 
al., 2008). Zoonoses, occur at human-animal-environment 
interfaces, thus highlighting the relevance of a One-health 
approach. Leptospirosis, caused by spirochetal bacteria 
of the Leptospira genus, is considered the most widely 
distributed zoonotic disease on the planet (Samsudin et al., 
2018). Leptospira has been isolated in many vertebrate taxa, 
including mammals, birds, amphibians, reptiles, and fish 
(Viera et al., 2018; Cilia et al., 2021), and has shown genetic 
heterogeneity. Leptospirosis represents a disease associated 
with poverty and low sanitation environments, both in rural 
and urban communities, as well as in livestock production 
areas, where close interaction with animals could favor the 
leptospirosis spread. It is also considered an occupational risk 
disease that affects persons who have contact with infected 
animals such as agricultural, livestock, meat, abattoir, and rice 
field workers, veterinarians, hunters, wild animals caretakers, 
and farmers (Richard and Oppliger, 2015; Bierque et al., 2020). 
It has been demonstrated that chronic leptospirosis 
can cause disability and significant economic losses. Howe-
ver, the infection can be confused with other febrile diseases 
such as dengue or influenza, due to its symptoms, and if 
not treated in time it could be lethal (Velasco-Castrejón et 
al., 2009). Nowadays, leptospirosis is endemic in many areas 
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and causes significant outbreaks after flooding events, it is 
a neglected disease not included in many infectious disease 
surveillance programs in humans and even less in animals. 
It is estimated that this infection is one of the main causes 
of economic losses related to livestock, causing reproductive 
problems in cattle, representing a potential agri-food vulne-
rability problem due to its impact on livestock production 
(Ellis, 2015; González and Macías, 2017; Garba et al., 2018). 
Due to complex interaction in the ecology and epide-
miology of the disease, and multiple animal host and human 
conditions in urban and rural settlements, it is important to 
identify the drivers and risk factors that promote infection 
in exposed people. Leptospirosis has a variable distribution 
worldwide, with Latin-America as one of the most affected 
regions (Schneider et al., 2017). We reviewed research ar-
ticles in databases (PubMed, Scopus, Web of Science and 
Google scholar, published from 1990 to 2020), using query 
terms related to leptospirosis/Leptospira biological and 
socioenvironmental drivers that influence its occurrence in 
Latin-America. South America is the most affected region, 
but also an increasing incidence in other latitudes is evident. 
Well established surveillance programs to identify serovars 
circulation, including animals, vaccination use and human 
behavioral interventions, are identified as important mea-
sures that will serve as a basis for the design of appropriate 
interventions to prevent and control the disease in humans 
and animals. 
Leptospirosis
Etiological agent and taxonomic classification
Leptospirosis is a zoonotic disease caused by bacteria 
commonly known as leptospires. The word has its roots in 
the Greek leptos meaning thin and the Latin spira that means 
rolled (Levett and Haake, 2014). Leptospires are gram-nega-
tive bacteria that have lipopolysaccharide (LPS) in the outer 
membrane, a cell wall with peptidoglycan, and an inner 
membrane (Cameron, 2015). They are spirochetes of the 
order Spirochaetales, belonging to the family Leptospiraceae 
within which three genera are included, Leptospira, Turneri-
ella and Leptonema (Levett, 2015). These organisms are dif-
ferentiated by their guanine and cytosine content (GC), their 
16s ribosomal RNA sequences and their DNA homology. The 
above allows classifying them in genres. Leptospira has a GC 
content of 33-43 %, Leptonema 54 % and Turneriella 53.6 % 
(Yasuda et al., 1987; Stackebrandt et al., 2013).
The Leptospira species have similarity in their mor-
phology, structure and size (Levett, 2015). They have a spiral 
shape with ends similar to a hook, giving it the appearance of 
a question mark. They have a length of 6-20 μm and a diam-
eter of 0.1 μm, as well as a wavelength of 0.5 μm. Pathogenic 
species isolated from mammals are more tightly rolled and 
shorter than saprophytic strains, while bacteria maintained 
under poor nutrient conditions have a more elongated 
structure and little motility (Cameron, 2015). The Leptospira 
virulence depends in large part on its LPS structure, which is 
the main recognized antigen during infection, and responsi-
ble for antigenic diversity and serogroup classification.
The serovar is the unit in which the Leptospira species 
are classified, and each exhibiting a different antigenic con-
formation. There are more than 300 serovars, which in turn 
have been classified by convenience in 32 serogroups, based 
on their antigenic homology (Caimi and Ruibal, 2020). Lepto-
spira are conventionally divided into two species, the patho-
genic Leptospira interrogans sensu lato and the saprophytic 
Leptospira biflexa sensu lato. Two strains will be considered 
as different serovars if, when performing a cross-aggluti-
nation absorption test (CAAT) with adequate amounts of a 
heterologous antigen, more than 10 % of the homologous 
titer consistently remains in at least one of the two antisera. 
An unknown isolated strain may correspond to a known 
serovar from which a reference strain, already existing or 
not, is considered as a reference strain for that serovar (WHO, 
2009). Although used for decades in Leptospira serological 
classification, CAAT is currently in disuse, due to technical 
limitation, and microagglutination test (MAT) has become 
the gold standard test (Caimi and Ruibal, 2020).
Also, increased availability of high throughout mo-
lecular methods, such as Next Generation Sequencing and 
DNA-DNA hybridization techniques, have provided tools for 
Leptospira biodiversity and genomic analysis, even in harsh 
soil and water environmental samples. Recent studies based 
in molecular taxonomy classification have discovered new 
clades and species. According to whole genome sequencing 
analyzes and molecular phylogenetics reconstruction by 
maximum likelihood of the 16s rRNA sequences, authors 
have identified 64 species in the genus Leptospira. Leptospira 
species are divided into three clades and one subclade. 
One of the clades includes pathogenic bacteria (P1) e.i, L. 
interrogans, L. kirschneri, L. noguchii, L. borgpetersenii, L. weilii, 
L. santarosai, L. alexanderi, L. alstonii, L.mayottensis, L. kmetyi. 
The other is an intermediate group (P2) e.i, L. wolffii, L. licera-
siae, L. Inadai, L. fainei, L. broomii and the third includes non-
pathogenic or saprophyte bacteria (S1) e.i, L. biflexa, L. idonii, 
L. meyeri, L. terpstrae, L. vanthielii, L. wolbachii, L. yanagawae, 
and others (Vincent et al., 2019; Guglielmini et al., 2019).
Clinical presentation and diagnostics in humans
The Leptospira incubation period lasts ≈ 10 days and 
the disease occurs 5-14 days after the entry of the bacteria. 
The infection is divided into two phases, acute and immune, 
and may be asymptomatic in some cases (Wynwood et al., 
2014). In 90 % of patients, the leptospirosis acute phase 
lasts around 7 days. In this clinical stage, known as anicte-
ric or benign, fever, photophobia, headache, arthralgia, 
chills, diaphoresis, asthenia, cough, nausea, vomiting and 
muscle pain can occur. In the immune phase, antibodies are 
produced (5-7 days after onset of infection), and excretion 
of the bacteria through urine starts when it establishes in 
the kidneys. However, in 5-10 % of cases there is an icteric 
or hepatonephrotic syndrome, also called Weil´s syndrome, 
with severe multi-organ dysfunction (Galloway et al., 2019). 
Death from this infection is commonly due to renal failure 
and pulmonary hemorrhage (Brett-Major and Coldren, 2012).
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Since the clinical manifestation of leptospirosis de-
pends on the contracted serovar (NOM-029-SSA2-1999), ade-
quate diagnosis is a valuable support tool. Diagnostic tests 
can be divided into immunological, genomic and darkfield 
microscopy methods (Rajapakse et al., 2015). The immunolo-
gical methods include the antibodies titration in serological 
samples by enzyme-linked immunosorbent assay (ELISA), 
and the gold standard method for leptospirosis diagnosis, 
microagglutination test (MAT). For MAT, titres ≥ 1:100 are 
considered positive, for individual or paired serum samples 
(WHO, 2009). In recent infections, titres ≥ 1:400 or fourfold 
increased between the acute and convalescent sample are 
classified as positive (Courdurie et al., 2017). The genomic 
methods for Leptospira detection, includes conventional 
PCR, real-time PCR, RT-PCR and isothermal amplification. 
These highly sensitive methods are based on the ampli-
fication of leptospiral constitutive genes, such as the 16S 
ribosomal RNA gene, the B subunit of DNA gyrase and secY, 
and genes specific to pathogenic species such as LipL32, lfb1 
and ompL1 (Ferreira et al., 2014; Waggoner and Pinsky, 2016).
Ecological and environmental drivers for Leptospira 
transmission
Abiotic factors
Leptospirosis occurrence varies greatly in the world. 
Certain climatic conditions, such as temperature (4-40 
°C), humidity greater than 20 %, and precipitation of each 
geographic location can favor the presence of Leptospira in 
some areas, being more frequent in tropical and subtropical 
climate, where the disease occurs throughout the year, while 
in temperate areas it occurs seasonally during the months 
with higher temperatures and rains. Leptospira also persists 
in nature, in soil and water at pH of 5.5-7.6, or even in cattle 
urine during 6-18 h at pH of 7-8 (Noguchi, 1918; Thibeaux et 
al., 2017). In addition, some serovars are capable of surviving 
up to 344 days in water and maintaining their virulence by 
regulating essential genes to promote survival even under 
extreme conditions of temperature and osmolarity, including 
the interaction with environmental bacteria and formation of 
biofilms, which allows them to survive in urine and increase its 
resistance to antibiotics (Vinod-Kumar et al., 2016; Barragan 
et al., 2017; Bierque et al., 2020). However, the complete infor-
mation about the Leptospira extrinsic and intrinsic conditions 
for surviving in environment, are still under investigation.
Biotic factors
Animals that contract leptospirosis are divided into 
natural or maintenance, and incidental reservoirs. In natural 
reservoirs, the infection is endemic; leptospirosis is acquired 
at an early age and is usually transferred by direct contact 
with another infected animal. Incidental hosts are those that 
acquire the infection by direct contact with the natural reser-
voirs or by indirect contact with water or soil contaminated 
with Leptospira. Some species can be natural hosts for some 
serovars and incidental reservoirs for others (Levett, 2001). In 
addition, the same species can be a natural reservoir of di-
fferent serovars in different regions of the planet (Hartskeerl 
and Terpstra, 1996; Putz and Nelly, 2020). The main natural re-
servoirs of pathogenic leptospires are wild and synanthropic 
species. The bacteria resides in the kidneys of these animals, 
and they commonly do not show clinical signs of the disease. 
The presence of Leptospira in wild animals including mam-
mals (mainly rodentia), birds, reptiles, and amphibians, have 
been thoroughly reviewed by Vieira et al. (2018) and Cilia et 
al. (2021), where many unconventional hosts were identified 
in North and Latin-American countries. Although wildlife has 
a real role in the Leptospira transmission cycles, information 
is still scarce for many regions of the world (Vieira et al., 2018). 
In turn, the wildlife that naturally hosts Leptospira can infect 
humans and livestock animals with an important role in food 
systems, also, companion animals become an important 
source of infection for humans (Table 1).
Leptospirosis in incidental hosts causes a variety of 
acute clinical manifestations, like fever, respiratory disea-
se, poor reproductive performance, low milk production, 
systemic failure, as well as urinary and hepatic insufficiency 
(Putz and Nally, 2020). However, in reservoirs, Leptospira can 
be present without causing major problems but could be 
eliminated through oral, renal, and reproductive ways (Ellis, 
2015; Loureiro and Lilenbaum, 2020). Hence, carriers without 
symptoms may spread the infection possibly throughout 
their whole lives (Thiermann, 1982). Incidental leptospirosis 
in cattle is caused by serovars such as Pomona, Grippotyphosa 
and Icterohaemorrhagiae, related to pigs, rodents, and wild-
life (Ellis, 2015). Natural leptospirosis is mainly caused by L. 
interrogans Hardjo, L. borgpetersenii Hardjo, L. santarosai Gua-
ricura, all of the Sejroe serogroup (Loureiro and Lilenbaum, 
2020). In swine, the most frequent serovars include L. Lora, 
Icterohaemorrhagiae, Pomona and Tarassovi (Petrakovsky et 
al., 2014). Due to its close contact with persons who work in 
the food production system, livestock animals play a critical 
role in the human-animal-environmental interface for Lep-
tospira transmission because it represents a potential source 
for natural or incidental Leptospira to humans. Putz and 
Nally (2020), reported a comprehensive analysis of Leptospira 
serovar interactions and its clinical manifestation in some 
important species, as well as reviews of seroprevalence in 
animals from Latin-America and the Caribbean (Pinto et al., 
2016; Pratt and Rajeev, 2018).
On the other hand, dogs are one of the most impor-
tant hosts for Leptospira in urban and rural settings, and are 
part of the transmission cycle. Infection caused by the serovar 
Canicola is considered the most common, being the contact 
with urine of infected dogs the main intra and inter-species 
route of transmission. Canine leptospirosis due to Icterohae-
morrhagiae serovar is less frequent, and is associated to the 
presence of rodents as these are the main carriers and trans-
mitters. Due to the behavioral habits of dogs such as sniffing, 
licking, and courtship, when several animals get together, 
intraspecies and interspecies transmission is favored, being 
stray dogs an important source of infection for “domiciled” 
dogs (Luna et al., 2008). The domestic cat is another impor-
tant companion animal that can be infected with Leptospira, 
however information is limited (Murillo et al., 2020). 
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Table 1. Selected studies on Leptospira serovar identification in human, companion animals and livestock in different Latin-America countries.
Tabla 1. Estudios selectos sobre identificación de Leptospira en humanos, animales de compañía y animales de producción en diferentes países de 
Latinoamérica.




Jorge et al., 2017
Oliveira et al., 2017
Ballum/Canicola/Hebdomadis/Icterohaemorrhagiae/Louisiana/Pomona/
Pyrogenes Cuba Rodríguez et al., 2018
Bratislava/Canicola/Grippotyphosa/Hardjo/Icterohaemorrhagiae/Pomona/




Campos et al., 2017
Fávero et al., 2018
Jorge et al., 2017
Autumnalis/Ballum/Bratislava/Canicola/Djasiman/Icterohemorrhagiae/
Mankarso/Tarassovi Caribbean island Saint Kitts Shiokawa et al., 2019
Bratislava/Canicola/Copenhageni/Grippotyphosa/Hardjo/Hebdomadis/
Pomona/Tarassovi Colombia Taddei et al., 2021
Hebdomadis/Pomona/Tarassovi Costa Rica Sequeira et al., 2016
Au s t ra l i s / Au t u m n a l i s / B at av i a e / Ca n i co l a / Co p h e n h a g e n i / H a rd j o /
Icterohaemorrhagiae/Pomona/Sejroe/Tarassovi Ecuador Ortega-Pacheco et al., 2020
Ballum/Canicola/Forthbragg/Grippotyphosa/Hardjo/Icterhaemorragiae Jamaica Brown et al., 2011
Bratislava/Canicola/Grippotyphosa/H89 hardjo prajitno/Hardjo/
Icterhaemorragiae/Inifap/Paloalto/Pomona/ Tarassovi/Wolffii México
Carmona-Gasca et al., 2011
Pedroza-Perez, 2008
Zárate-Martínez et al., 2015
Swine





Miraglia et al., 2008
Miraglia et al., 2012
Moreira et al., 2018
Valença et al., 2013
Bratislava/Copenhageni/Djasiman/Icterohaemorrhagiae/Mankarso Caribbean island Saint Kitts Shiokawa et al., 2019
Canicola/Grippotyphosa/Hardjo/Icterohaemorrhagiae/Pomona Colombia Ospina-Pinto et al., 2019
Bataviae/Canicola/Hardjo/Icterohaemorrhagiae Ecuador Ortega-Pacheco et al., 2020
Bratislava/Forthbragg/Pomona Jamaica Brown et al., 2011
Ballum/Bataviae/Canicola/Djasiman/Hebdomadis/Lousiana/Panama/Pomona/






Almeida et al., 2019
Campos et al., 2017
Costa et al., 2016
Copenhageni/Djasiman/Hardjo/Icterohaemorrhagiae/Mankarso/Pomona Caribbean island Saint Kitts Shiokawa et al., 2019
Canicola/Gripotyphosa/Hardjo/Icterohaemorrhagiae/Tarassovi Ecuador Orlando et al., 2020
Kennewicki Uruguay Hamond et al., 2014
Goat
Australis/Bratislava/Canicola/Icterohaemorrhagiae/Pomona/Pyrogenes/Wolffi Brazil Campos et al., 2017
Bratislava/Djasiman/Hardjo/Mankarso Caribbean island Saint Kitts Shiokawa et al., 2019
Hardjo-prajitno/Icterohemorrhagiae Mexico Gaytán-Camarillo et al., 2021
Dog
Ballum/Butembo/Canicola/Copenhageni/Hond Utrecht IV/Kito Brazil Jorge et al., 2017Miraglia et al., 2012
Canicola/Hardjo/Icterohaemorrhagiae/Grippotyphosa Ecuador Orlando et al., 2020
Ballum/Bratislava/Canicola17/Grippotyphosa/Icterohaemorrhagiae/
Pyrogenes/Shermani México
Hernández-Ramírez et al., 
2017
Copenhageni Trinidad Suepaul et al., 2010
Cat
Andamana/Autumnalis/Bataviae/Canicola/Patoc Brazil Dos Santos et al., 2017
Autumnalis/Copenhageni Chile Azócar-Aedo et al., 2014Dorsch et al., 2020




Dewes et al., 2020
Jorge et al., 2017
Canicola/Copenhageni/Sejroe/Cynopteri/Hardjo/Pomona/Autumnalis/
Icterohaemorrhagiae/Grippotyphosa/Bataviae/Tarassovi/Australis Ecuador Orlando et al., 2020
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Occupational and behavioral drivers for Leptospira trans-
mission
Occupational diseases are those acquired when 
exposed to risk factors related to work (WHO, 2002). Leptos-
pirosis is considered an occupational disease for agricultural, 
livestock, meat, abattoir, and rice field workers, veterinarians, 
hunters, caretakers of wild animals, and farmers (Bengis et al., 
2004; Bierque et al., 2020). This occurs due to close contact 
with animals which increases the risk of being exposed to 
potentially contaminated carcasses or live animals with Lep-
tospira (WHO, 2009).
According to epidemiological estimates, 30 % of lep-
tospirosis cases are due to occupational exposure (Richard 
and Oppliger, 2015). Most of the infectious agents that cause 
zoonotic diseases are considered occupational risk factors, 
since they occur sporadically or chronically in different pro-
fessions. Livestock worker’s activities (such as milking) which 
include contact with animal urine, increase exposure and risk 
of leptospirosis. In addition, making homemade cheese and 
washing hands or drinking water from cattle drinking foun-
tains could be risk factors. In addition, the risk of contracting 
the infection is greater in personnel that assist in the livestock 
delivery and manipulate waste products, and it is aggravated 
when not wearing personal protective equipment (PPE) 
(WHO, 2009). There is also a greater risk in cattle owners or in 
people, whose occupation involves the manipulation of pig 
or bovine tissues (Leal-Castellanos et al., 2003). Carrying out 
necropsies on mortality events and obstetric management 
of sows is a routine activity on technified farms, and due the 
asymptomatic presentation of the disease, it represents a 
high risk for workers (Botazzo et al., 2002). In addition, wor-
kers previously diagnosed with leptospirosis are more likely 
to be seropositive than those who have not previously had 
the disease. This suggests that those who already suffered 
from the disease may present behaviors that increase their 
exposure (Sanhueza et al., 2017).
Moreover, people who do outdoor activities are more 
at risk of contracting leptospirosis than those who work in-
doors (Kamath et al., 2014). In a meta-analysis study carried 
out in 7,000 feverish cases globally associated with travelers, 
a prevalence of 0.21-2.65 % for Leptospira was found (Ban-
dara et al., 2014). Other behaviors that increase the risk of 
getting sick are swimming in areas where cattle drink water, 
and keeping puddles near the house. Likewise, people with 
skin cuts exposed to floodwater are at greater risk of having 
leptospirosis (Leal-Castellanos et al., 2003).
In addition, other studies revealed that having fre-
quent contact with animals such as rats, mice, guinea pigs 
and poultry, or living with pets such as dogs, cats, and rats, 
and walking barefoot, increases the risk of leptospirosis 
(Brockmann et al., 2016; Sanhueza et al., 2017). Other risk 
factors associated with leptospirosis in humans, are the 
limited knowledge of the disease and its transmission, low 
educational attainment, younger age, and unhealthy beha-
viors (inadequate or missing hand washing and PPE) (Brown 
et al., 2011). Also, belonging to the male gender, working age, 
working in the field, and poverty, are risk factors associated 
with the disease (Carvajal and Fagerstrom, 2017; Dhewantara 
et al., 2018).
Transmission of Leptospira at human-animal-environ-
ment interfaces
After a Leptospira infection, natural reservoirs, such as 
herbivores and other animals, may become asymptomatic 
carriers and, in consequence, an important source of Lep-
tospira shedding into the environment by bacteria secretion 
in urine. This is a renal carrier state and considered the most 
important mechanism that enables the persistence of leptos-
pirosis in the environment (Adler and de la Peña-Moctezuma, 
2010). Therefore, during its life cycle it can be transmitted to 
incidental hosts, such as humans or domestic livestock, Figure 
1 (Bengis et al., 2004; Ko et al., 2009; Haake and Levett, 2015). 
Once the leptospires enter a new host, they spread through 
the peritubular capillaries or glomeruli to the kidneys, via 
the hematogenous route. When they enter the renal tubular 
lumen, they invade the brush border of the proximal tubule 
through which urine is eliminated (Haake and Levett, 2015).
After direct exposure to infected urine, milk or re-
productive fluids of carrier animals, or indirect exposure to 
soil, water or food contaminated with the bacteria (Galloway 
et al., 2019), Leptospira can enter a new host through skin 
lesions and oral, genital, nose, or conjunctive mucous mem-
Figure 1. The cycle of Leptospira transmission influenced by environmen-
tal factors. Occurrence is affected by the transmission dynamics between 
asymptomatic and synantropic (rodents) wild reservoirs carriers, and other 
wildlife, environmental, and domestic and livestock that acts as incidental 
or reservoir hosts. Transmission to human is mediated by contact with 
hosts or direct by contaminated water and soil. Pathogenic Leptospira pen-
etrates through mucous membranes and skin lesions (Levet, 2015) (Created 
by BioRender.com).
Figura 1. El ciclo de transmisión de Leptospira influenciado por factores 
ambientales. 
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branes. Although indirect contact is the most common form 
of Leptospira transmission, direct contact is also associated 
with occupational transmission (Haake and Levett, 2015).
Humans can excrete leptospires in urine for several 
weeks, and even years after the acute phase of the disease 
(Bharti et al., 2003). However, there is no evidence supporting 
this as an important source of Leptospira in the environment, 
since their urine is acidic and leptospires require a pH of 6-8 
to survive, therefore, human-to-human transmission is rare 
(Castillo-Hernández, 2014; Kamath et al., 2014). Leptospira can 
also spread through sexual intercourse (Harrison and Fitzge-
rald, 1988). In addition, mothers can infect the fetus through 
the placenta, which can cause fetal death or miscarriage, the 
latter being more common in women who have developed 
leptospirosis in the first months of pregnancy (Haake and 
Levett, 2015). Although the mother’s disease not necessarily 
affects the fetus (Shaked et al., 1993), the baby could acquire 
the infection during breastfeeding (Bolin Koellner, 1988). In 
addition, blood can also participate as an infectious medium 
since the bacteria are present in it the first 10 days of infec-
tion (Budihal and Perwez, 2014).
Epidemiology of human leptospirosis 
Annually there are approximately 1.03 million cases of 
leptospirosis and 58,900 deaths worldwide, and is one of the 
zoonoses that causes more morbidity and mortality globally 
(Costa et al., 2015). The incidence is seasonal, and can be 
associated with climatic conditions; in temperate regions the 
incidence rate is 0.1-1 / 100,000 inhabitants, in humid tropi-
cal climates the incidence rate is 10 / 100,000 inhabitants, 
and in regions with outbreaks or with risk groups is 100 / 
100,000 inhabitants (WHO, 2009). There is a greater number 
of cases in rainy seasons in warm and dry regions, since water 
provides the means of survival for Leptospira (Levett, 2004). 
In addition, it is endemic to tropical and subtropical zones, 
such as Latin-America and the Caribbean (Adler and de la 
Peña-Moctezuma, 2010). South America is the most affected 
region, despite many cases are reported in other northern 
countries (Schneider et al., 2017; Pereira et al., 2018).
In a meta-analysis assessment of 17 studies carried out 
in different Latin-American countries (including Colombia 
and Puerto Rico), a prevalence of 16 % was found in 13,539 
cases with acute fever (Moreira et al., 2018). In another meta-
analysis study using data provided by health authorities from 
different Latin-American and Caribbean countries, based on 
data published in the 2006-2013 period, the countries with 
the highest prevalence reports were Trinidad and Tobago 
with 22 / 100,000 inhabitants, and Uruguay with 13.9 / 
100,000 inhabitants. The countries that reported the highest 
proportion of positive cases for Leptospira were Guyana with 
37 %, Jamaica with 31.9 %, Cuba with 27.6 %, Peru with 27.3 
% and Argentina with 22.4 % (Pulido-Villamarín et al., 2014).
In a study conducted by Meny et al. (2019), in a region 
of Uruguay, a Leptospira seroprevalence of 46 % was found; 
in addition, the contact with animals and unsafe water con-
ditions were observed as the main risk factors (Meny et al., 
2019). On the other hand, in a retrospective study carried 
out by the Costa Rican Ministry of Health in the period 
2011-2015, a prevalence of 10.6 % was found in 5,056 pa-
tient samples (Carvajal and Fagerstrom, 2017). A descriptive 
epidemiological study carried out in Brazil, described the 
confirmed cases for the 2007-2016 period, reporting 39,263 
cases with an annual mean of 3,926 and an incidence of 1.02 
/ 100,000 inhabitants. They also estimated a lethality of 8.9 % 
with a distribution of 79.2 % in urban areas with little sanitary 
infrastructure, which predisposed the infestation by rodents 
and contact with water and/or flood mud (Flores et al., 2020). 
In Latin-America through national surveillance programs 
during 2010-2014, cases mainly distributed in Brazil, Peru, 
Colombia, and Ecuador (Schneider et al., 2017).
In México, during a dengue outbreak in the Yucatan 
Peninsula, it was found that 14 % of suspected dengue cases 
patients had leptospirosis. The symptoms and signs that 
manifested the positive people to Leptospira belonged to 
the anicteric presentation, and were like those of dengue. 
The serovars found were Canicola, Pomona and Grippo-
typhosa (Zavala-Velázquez et al., 1998). Since leptospirosis 
clinical presentation is confused with other febrile diseases, 
is considered a public health problem that is not addressed 
and is underdiagnosed (Velasco-Castrejón et al., 2009). In 
Tamaulipas, 8.2 % of the trail workers had seropositivity to 
leptospirosis and the predominant serovars were Bratislava 
and Hardjo; two people had antibodies for three serovars, 
eight for two and fourteen for only one (Rodríguez-Parra et 
al., 2009).
In Mexico, during 1992-1997, the National Institute 
of Epidemiological Diagnosis and Reference found a se-
ropositivity of 30.3 % for leptospirosis. The most common 
serovars were Pomona, Canicola and Icterohaemorrhagiae. 
Later, in 1998, they registered 119 leptospirosis cases and the 
majority was concentrated in Distrito Federal, Hidalgo and 
Guerrero (NOM-029-SSA2-1999). During 2000-2010, there 
were 1,547 cases and 198 deaths by leptospirosis in Mexico 
(Sanchez-Montes et al., 2015). Therefore, the case-fatality rate 
was 12.8 %, higher than Malaysia (1.47 %) (Tan et al., 2016), 
Trinidad and Tobago (5.8 %) (Mohan et al., 2009) and Hawaii, 
United States (0.5 %) (Katz et al., 2011). This could be due to 
the delay in the diagnosis, the confusion of the symptoms 
with those of other diseases or an adequate treatment (Bu-
dihal and Perwez, 2014). The only states that did not present 
cases were Durango, Baja California, Queretaro, Guanajuato, 
and Zacatecas. While those with the highest incidence were 
Veracruz, Tabasco, and Sinaloa, the actual number of people 
who had leptospirosis is unknown (Sanchez-Montes et al., 
2015). It was determined that leptospirosis cases in Mexico 
occur throughout the year, however endemic peaks were 
observed during the months of August, September, and 
October (Yescas-Benitez et al., 2020). 
In several studies conducted in different regions of 
Mexico, in occupational exposed workers and rural commu-
nities, authors found a 12-40 % seroprevalence (Leal-Caste-
llanos et al., 2003; Rivera-Benitez et al., 2014; Vado-Solís et al., 
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2014; Alvarado-Esquivel et al., 2015; Cordova-Robles, 2019). 
The main serovars were Canicola and Hardjo, indicating that 
dogs and cattle are an important source of contagion for 
livestock workers. Although Mexico has a surveillance and 
control program for leptospirosis outbreaks, many cases 
might not be detected due to lack of differential diagnosis 
with other febrile illnesses or mild/asymptomatic cases. 
Prevention and control measures
Vaccines and prophylaxis
The application of vaccines in humans and animals, is 
an option to prevent leptospirosis, and some vaccines may 
protect against serovars different from the one used to ma-
nufacture them due to cross-reactivity (Matsuo et al., 2000). 
However, they can be serotype dependent and unable to 
induce an immune response against other serovars (Sonrier 
et al., 2000). In addition, the genetic and phenotypic diversity 
of infectious leptospires is an obstacle to the development 
of vaccines (Grassmann et al., 2017). Only one country in 
Latin-America, Cuba, uses routinely human vaccination 
against Leptospira (Pereira et al., 2018), Normally using inac-
tivated vaccines applied to domestic animals and livestock. 
In some countries, it is also applied to human populations 
at risk. However, due to side effects in humans, lack of cross 
protection and short duration of immunity, they are not used 
globally (Grassmann et al., 2017). 
Several vaccines are available; bacterins are vaccines 
made from whole dead cells and are the most common 
type of biologic available globally. The disadvantages are 
high production costs, local and systemic reactions, and a 
short period of immunity. In addition, protection is restric-
ted to antigenically related serovars. Therefore, polyvalent 
vaccines have been used in domestic animals such as cattle. 
The immune protection can last from 6 months to 3 years 
depending on the adjuvants used in the vaccine, and human 
vaccine formulations have shown efficacy rates of 60-100 % 
(Koizumi and Watanabe, 2005).
Recombinant DNA vaccines have advantages such as 
low production cost, stability, and ability to elicit humoral 
and cell-mediated immune response against several serovars 
in the long term. DNA vaccines have been designed against 
conserved genes among the pathogenic leptospires and are 
highly immunogenic. The insertion of genes such as LipL32, 
OmpL1 and LipL41 in different vectors have been tested as 
vaccines in animal models (Bashiru and Bahaman, 2018).
Another alternative available against leptospirosis 
is chemoprevention prophylaxis, mainly used when the 
infection risk is high and there will be a forced exposure. 
Oral ingestion of a weekly 200 mg dose of doxycycline has 
been effective in reducing clinical infection, but it does not 
prevent infection, although significantly reduces morbidity 
and mortality (Sehgal et al., 2000).
Hygiene, PPE and environmental control
Among the leptospirosis prevention measures, is the 
use of protecting clothing that covers wounds and reduces 
the risk of disease appearance (OMS, 2008), as well as per-
sonal protection equipment such as overalls, gloves, boots, 
and goggles, when in contact with livestock, preventing skin 
and mucous membranes exposure (NOM-029-SSA2-1999). 
To prevent leptospirosis, hands should be washed after 
contact with animals and their derivatives, and rodent po-
pulation, should be controlled. In addition, it is necessary to 
disinfect animal breeding sites. Furthermore, people should 
have regular clinical and laboratory tests, especially if there 
is a suspicion of infection. Vaccination of cattle and pets is 
also necessary. It is important to avoid swimming in waters 
that animals have access to, adding chlorine to water sources 
for human use, and boiling it before consumption. Likewise, 
avoiding the formation of water clusters in work areas is 
important to reduce the potential for leptospirosis outbreaks 
(NOM-029-SSA2-1999). 
Education and interventions
The risk of infection is reduced by avoiding contact 
with the carrier host or contaminated environment. It is im-
portant to raise awareness among the population, especially 
at-risk groups, about leptospirosis, so an early detection 
and adequate treatment is possible (WHO, 2009). This is 
achievable through education campaigns or interventions 
promoting preventive health behaviors among high-risk 
groups (Rahman et al., 2018).
Surveillance and future challenges
Surveillance systems and health policies for human 
leptospirosis in Latin-America have been reviewed previously 
by Schneider et al. (2017) and Pereira et al. (2018). The identi-
fication of Leptospira reservoirs, and the understanding of the 
eco-epidemiology of the bacteria in the environment and 
in animal hosts, are key in designing strategies for control. 
Different serovars of Leptospira may differ in their virulence, 
so the true magnitude of the health risk due to leptospirosis 
is unknown. On the other hand, it is possible for the infec-
tion to remain asymptomatic and undiagnosed, resulting 
in an underestimation of the seroprevalence. Therefore, it is 
necessary to investigate which serovars are in the affected 
area to implement or improve vaccination strategies, and 
determine the actual number of people that are seropositive 
(Richard and Oppliger, 2015; Sanchez-Montes et al., 2015). 
Once taught as a predominant disease in tropical countries, 
some researchers estimate that climate change will increase 
distribution range due to changes in temperature, extreme 
rainy season and flooding events that will increase occurren-
ce of Leptospira and leptospirosis in the next years (Lau et al., 
2010), thus many gaps in knowledge need to be addressed.
CONCLUSIONS
Leptospirosis is a re-emerging zoonotic disease of 
global importance. Human and animal leptospirosis cases 
are increasingly detected in many regions and territories in 
rural and urban settings in Latin-America, mainly in South-
American countries. Serovar, host diversity and socio-
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environmental conditions mediate complex interactions of 
its ecology and epidemiology in this region. Diagnosis of 
leptospirosis is not conducted systematically in all regions 
of Latin-America, including Mexico, although surveillance 
of the disease in human and animal with appropriate diag-
nostic methods might play an important role in prevention 
and control of leptospirosis outbreaks. Also, risk mitigation 
measures in occupational exposed populations through 
modifications in behavioral determinants, animal vaccina-
tion and educational interventions might help decrease 
transmission to human hosts. Although leptospirosis is an 
important zoonotic disease at human-animal-environmental 
interfaces, it is neglected and underdiagnosed. Studies with 
a One Health approach in Latin-American regions are rele-
vant and necessary, representing a challenge for public and 
animal health, and food systems.
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